🔴 Aquestive Therapeutics is trading 5% down today amid broad market and biotech pressure

Aquestive Therapeutics is trading at $3.60, down 5.13%, amid broad risk-off pressure across biotech and markets.

• XBI is down 5.19% alongside steep declines in major indexes.
• The recent Q3 revenue and earnings miss remains relevant background; reporting showed a modestly positive after-hours reaction, but does not establish the cause of the November 5 decline.
• The company also announced an ACAAI data presentation, with no reported link to the drop.